MADWORLDDETOX
Periwinkle Derivative — Cerebral Vasodilator

Vinpocetine: Delivering ATP to the Brain

The brain is 2% of body weight and consumes 20% of cardiac output. When that blood supply falters — small-vessel disease, post-stroke, post-concussion, awakening-era cerebral demand — cognition collapses. Vinpocetine selectively dilates cerebral microvasculature without dropping systemic pressure.

10 min readUpdated May 2026

Quick Facts

Source

Semi-synthetic derivative of vincamine from Vinca minor (lesser periwinkle)

Discovered

Csaba Szantay, Hungary, 1975 (Gedeon Richter)

Regulatory Status

Prescription in EU/Asia (Cavinton); FDA delisted as a dietary supplement 2019

Half-life

2-4 hours; take 2-3x daily

Actions

Selective cerebral vasodilator, PDE1 inhibitor, Na+ channel blocker, neuroprotectant

Best For

Cognitive decline, post-stroke, vertigo, tinnitus, age-related blood-flow loss

What It Is

Vinpocetine is a semi-synthetic ethyl ester of apovincamine, itself derived from vincamine — an alkaloid found in the lesser periwinkle (Vinca minor), a European groundcover plant. Hungarian chemist Csaba Szantay synthesized it at Gedeon Richter in 1975, where it has been a flagship neurology prescription since. In the EU and East Asia, it is sold under names like Cavinton for cerebrovascular insufficiency, vertigo, and post-stroke cognitive recovery.

In the US, vinpocetine occupied a gray zone as a dietary supplement until the FDA ruled in 2019 that it does not meet the statutory definition of a dietary ingredient (because it was first marketed as a drug abroad). It is still widely sold but its regulatory future is uncertain. Source carefully.

How It Works

Four Mechanisms

1.
Selective cerebral vasodilation

Increases blood flow to ischemic and underperfused regions of the brain without affecting systemic blood pressure. Mediated through smooth muscle cAMP elevation specifically in cerebral arterioles. This is the key practical effect — you do not get the orthostatic hypotension of systemic vasodilators.

2.
PDE1 inhibition

Phosphodiesterase-1 is the calcium-activated form expressed predominantly in cerebral vasculature. Inhibition raises intracellular cAMP, relaxing smooth muscle. Mechanism behind the vascular effect; mechanism of action shared by some asthma and pulmonary hypertension drugs targeting other PDE isoforms.

3.
Use-dependent Na+ channel blockade

Blocks voltage-gated sodium channels in over-firing neurons. Provides neuroprotection in ischemia and may explain effects on tinnitus and certain epileptogenic foci. Similar mechanism to phenytoin but with very different overall pharmacology.

4.
Brain glucose and oxygen extraction

Increases neuronal uptake of glucose and oxygen, raising ATP production per unit of blood flow. Bonoczk et al. used PET imaging to demonstrate this effect in stroke patients. The molecule effectively makes each milliliter of cerebral blood do more work.

Strongest clinical evidence: post-stroke cognitive recovery (Szilagyi et al.), age-related cognitive decline (Hindmarch and others), vertigo of cerebrovascular origin (Oosterveld), and tinnitus (Konopka). Cochrane review on dementia is cautious but consistent.

Kundalini & Awakening Support

Jana Dixon emphasizes that the kundalini brain is metabolically extraordinary — cerebral glucose demand and oxygen consumption rise dramatically during active awakening, particularly in the limbic and prefrontal areas processing the experience. Practitioners frequently report air hunger, mental fatigue after even brief cognitive effort, and a sensation of cerebral "heat" that does not resolve until rest.

Vinpocetine 10-30 mg/day, divided, supports the supply side of this equation. By increasing cerebral microcirculation and the brain's ability to extract oxygen and glucose from the blood that does arrive, it reduces the cognitive fatigue and air-hunger sensation many awakening-era users describe. Often paired with piracetam (improves interhemispheric processing) and CoQ10 (mitochondrial ATP output) for a layered cerebral support stack.

The tinnitus benefit is also relevant — many practitioners report awakening-era auditory phenomena, and vinpocetine reduces vascular-component tinnitus in clinical trials.

Detox Benefits

  • Post-stroke / post-concussion — accelerates clearance of damaged tissue and microglial activation products.
  • Cerebral microcirculation — opens small vessels, improving clearance of metabolic waste via the glymphatic system.
  • Neuroprotection from oxidative stress — sodium channel modulation reduces excitotoxic damage.
  • Anti-platelet effect — mild reduction in platelet aggregation supports cerebral microclot clearance.

Dosing Protocol

Cognitive Support / Maintenance

  • • 10 mg, 3x daily with meals
  • • Take with fatty food (lipophilic, absorption depends on fat)
  • • Effect noticeable in 1-2 weeks; full benefit by 6-8 weeks

Post-Stroke / Cognitive Decline (Higher Dose)

  • • 20-30 mg/day, divided into 2-3 doses
  • • EU prescription range for cerebrovascular insufficiency
  • • Coordinate with neurology

Tinnitus / Vertigo

  • • 10 mg, 3x daily
  • • 8-12 week trial; if no benefit, discontinue
  • • Pair with ginkgo biloba 120-240 mg for additive vascular effect

Nootropic Stack (with Piracetam)

  • • Vinpocetine 10 mg + piracetam 1.6 g + alpha-GPC 300 mg, 2x daily
  • • The classic Eastern European cerebral-blood-flow stack
  • • Always include choline cofactor

Contraindications & Cautions

  • Pregnancy: ABSOLUTE CONTRAINDICATION. NIH reproductive toxicity data showed miscarriage and birth defects in animal studies. The FDA explicitly warned in 2019 not to take during pregnancy or in women planning conception.
  • Anticoagulants / antiplatelets: Additive bleeding risk. Avoid with warfarin, aspirin, clopidogrel, fish oil, ginkgo.
  • Surgery: Discontinue 2 weeks before any surgery.
  • Hypotension: Mild blood pressure lowering possible; watch in patients on antihypertensives.
  • Lactation: Insufficient safety data; avoid.
  • Severe coronary disease: Vasodilatory effects could precipitate angina in unstable cases.
  • GI upset, headache, sleep disturbance: Reported in a minority; usually resolves with dose reduction.
  • Regulatory: Not legal as a dietary supplement in the US after 2019 FDA action. Source carefully; verify identity and purity.

Best Products

Source Naturals — Vinpocetine 10 mg

Long-standing single-ingredient vinpocetine product with consistent third-party identity testing. Standard clinical dose.

Check Price on Amazon →

Jarrow Formulas — Vinpocetine 5 mg

Lower-dose for flexible titration and stacking with other cerebral support compounds.

Check Price on Amazon →

Related Ingredients